HEAL Initiative: Advancing Health Equity in Pain and Comorbidities

The National Institutes of Health (NIH) is currently accepting applications for its HEAL Initiative: Advancing Health Equity in Pain and Comorbidities to develop, test, and implement novel, culturally-appropriate pain interventions and/or adapt, test and evaluate efficacy and effectiveness of existing pain interventions, in populations that disproportionately experience negative health outcomes.

Donor Name: National Institutes of Health (NIH)

State: All States

County: All Counties

Type of Grant: Grant

Deadline (mm/dd/yyyy): 03/22/2022

Grant Size: $500,000

Grant Duration: 5 years

Details:

This FOA is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to (1) improve treatment for opioid misuse and addiction and (2) enhance pain management.

The scope of this initiative includes but is not limited to:

Adapting and testing existing evidence-based interventions for chronic pain to culturally-tailored interventions for specific HDPs.
Developing and testing culturally-tailored interventions that target biological, psychological and social stressors that exacerbate chronic pain and comorbidities in HDPs.
Developing interventions that target common underlying mechanisms between comorbid pain and other chronic conditions.
Developing and testing novel SDOH-driven, culturally-tailored interventions that target chronic pain and comorbid conditions.
Improving multidisciplinary care for populations at disproportionate risk of pain and comorbidities.

Funding Information

Application budgets are not limited but need to reflect the actual needs of the proposed project. It is strongly recommended that applicants not request a budget of more than $500,000 in direct costs per year for the R61 phase and $1,000,000 in direct costs per year for the R33 phase.
The scope of the project should determine the project period for each phase. The maximum period of the combined R61 and R33 phases is 5 years, with 1 to 2 years for the R61 phase and up to 4 years for the R33 phase.

Eligibility Criteria

Public and State controlled institutions of higher education
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Independent school districts
State governments
Small businesses
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
City or township governments
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.